Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia
D. A. Pollyea,
B. M. Stevens,
C. L. Jones,
A. Winters,
S. Pei,
M. Minhajuddin,
A. D’Alessandro,
R. Culp-Hill,
K. A. Riemondy,
A. E. Gillen,
J. R. Hesselberth,
D. Abbott,
D. Schatz,
J. A. Gutman,
E. Purev,
C. Smith,
C. T. Jordan
December 2018